Patrick Frankham

Patrick Charles Frankham is the founder of Lanco Biosciences, Inc., founded in 2008.
Dr. Frankham was the founder of Venn Life Sciences Holdings Plc, founded in 2008, and served as President from 2008 to 2010.
Dr. Frankham was the founder of Interlife Sciences, Inc., founded in 2009, and served as President from 2009 to 2012.
Former jobs include President, CEO & VP-Business Development at BetterLife Pharma, Inc. in 2019; Chairman & Chief Executive Officer at Ullman Medical, Inc. from 2010 to 2012; Chief Executive Officer at Mondias Natural Products, Inc. from 2019 to 2020; Chief Executive Officer at Lumiera Health, Inc.; Chairman at Vansen Pharma, Inc.; Executive Director-Business Model at Boehringer Ingelheim GmbH; Director at Okana Ventures, Inc. in 2013; Director-Preclinical Development at Endoceutics, Inc. from 1996 to 1998; Director-Regulatory Science at BioAxone Therapeutic, Inc. from 2005 to 2007; Director-Preclinical & Regulatory Development at Aeterna Zentaris GmbH from 1998 to 2005; Chief Operating Officer at Helix BioPharma Corp.
from 2016 to 2017; Vice President-International at Aptus Health, Inc.; General Manager at ICON Clinical Research (Canada), Inc. from 2007 to 2009; Vice President-Scientific Affairs at Alterhealth, Inc. from 2010 to 2012; Chief Operating Officer at MedMelior, Inc. Education includes an MBA from The University of Liverpool, a doctorate from Université Laval, and an undergraduate degree from the University of Nipissing conferred in 1994.